Hydrodynamic, electron microscopic, and ligand-binding analysis of the Epstein-Barr virus/C3dg receptor (CR2)
- PMID: 2555366
Hydrodynamic, electron microscopic, and ligand-binding analysis of the Epstein-Barr virus/C3dg receptor (CR2)
Abstract
The interaction of the Epstein-Barr virus/45-kDa proteolytic fragment of C3 (C3dg) receptor (CR2) with its viral ligand, the Epstein-Barr virus glycoprotein gp350/220, initiates the sequence of events leading to virus internalization and B lymphocyte transformation. Soluble recombinant receptor (rCR2) and gp350/220 as well as the natural ligand, C3dg, were subjected to a number of analytical techniques including gel permeation chromatography, density gradient ultracentrifugation, circular dichroism, and electron microscopy in order to determine their hydrodynamic, structural, and binding properties. Both rCR2 and gp350/220 were found to be highly extended proteins (f/fo = 2.1 and 2.4/2.2, respectively). C3dg, in contrast to the viral ligand, is only somewhat elongated (f/fo = 1.5). Soluble rCR2, visualized by high resolution electron microscopy, was shown to be an extended, highly flexible molecule comprised of ringlet domains, each approximately 24.1 A in length, which likely correspond to the short consensus repeat motif deduced from the CR2 cDNA nucleotide sequence. Ligand-binding studies carried out under physiological conditions indicated that gp350/220 binding to rCR2 was saturable and univalent, with a dissociation constant of 3.2 nM. In contrast, monomeric C3dg did not bind to rCR2 under physiological conditions; however, at reduced ionic strength, monomeric C3dg binding could be measured. These studies indicate that the affinity of the C3dg monomer for rCR2 under physiologic conditions is approximately 10(4)-fold less than that of the viral ligand. The molecular properties of rCR2 revealed in these studies provide essential information for future studies of the biologic functions of the Epstein-Barr virus/C3dg receptor.
Similar articles
-
Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection.J Biol Chem. 1990 Jul 25;265(21):12293-9. J Biol Chem. 1990. PMID: 1695627
-
Determination of the structural basis for selective binding of Epstein-Barr virus to human complement receptor type 2.J Exp Med. 1991 Dec 1;174(6):1299-311. doi: 10.1084/jem.174.6.1299. J Exp Med. 1991. PMID: 1660522 Free PMC article.
-
Structural studies in solution of the recombinant N-terminal pair of short consensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg.Biochemistry. 2001 May 22;40(20):5931-41. doi: 10.1021/bi0101749. Biochemistry. 2001. PMID: 11352728
-
CR2 complement receptor.J Invest Dermatol. 1990 Jun;94(6 Suppl):112S-117S. doi: 10.1111/1523-1747.ep12876069. J Invest Dermatol. 1990. PMID: 2161885 Review.
-
The Structure-Function Relationships of Complement Receptor Type 2 (CR2; CD21).Curr Protein Pept Sci. 2016;17(5):463-87. doi: 10.2174/1389203717666151201192124. Curr Protein Pept Sci. 2016. PMID: 26916158 Review.
Cited by
-
Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19.J Exp Med. 1991 Jan 1;173(1):55-64. doi: 10.1084/jem.173.1.55. J Exp Med. 1991. PMID: 1702139 Free PMC article.
-
Structural biology of complement receptors.Front Immunol. 2023 Sep 11;14:1239146. doi: 10.3389/fimmu.2023.1239146. eCollection 2023. Front Immunol. 2023. PMID: 37753090 Free PMC article. Review.
-
Central modules of the vaccinia virus complement control protein are not in extensive contact.Biochem J. 1999 Nov 15;344 Pt 1(Pt 1):167-75. Biochem J. 1999. PMID: 10548547 Free PMC article.
-
Biophysical investigations of complement receptor 2 (CD21 and CR2)-ligand interactions reveal amino acid contacts unique to each receptor-ligand pair.J Biol Chem. 2010 Aug 27;285(35):27251-27258. doi: 10.1074/jbc.M110.106617. Epub 2010 Jun 17. J Biol Chem. 2010. PMID: 20558730 Free PMC article.
-
Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis.Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10996-1001. doi: 10.1073/pnas.93.20.10996. Proc Natl Acad Sci U S A. 1996. PMID: 8855297 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous